Home › Companies › Madrigal Pharmaceuticals, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Madrigal Pharmaceuticals, Inc.’s Form 8-K, filed June 17, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 17, 2026: 7 items on Madrigal Pharmaceuticals, Inc.’s Form 8-K, filed June 17, 2026: 3 elected · 4 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Madrigal Pharmaceuticals, Inc. in the interactive database Compare manager voting policies
These tallies are Madrigal Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Julian C. Baker | 17,363,250 | -- | -- | 2,227,734 | 1,731,844 | 89% | Elected | — |
| Elect Director: Daniel J. Brennan | 19,469,200 | -- | -- | 121,784 | 1,731,844 | 99.3% | Elected | — |
| Elect Director: James M. Daly | 18,921,185 | -- | -- | 669,799 | 1,731,844 | 97% | Elected | — |
| 2. On a non-binding, advisory basis, the compensation of the Company's named executive officers | 19,000,895 | 561,058 | 29,031 | -- | 1,731,844 | 97% | Approved | — |
| 3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 21,256,315 | 37,505 | 29,009 | -- | -- | 99.8% | Approved | — |
| 4. The 2026 Stock Plan | 19,118,851 | 446,394 | 25,739 | -- | 1,731,844 | 98% | Approved | — |
| 5. The 2026 ESPP | 19,546,766 | 22,948 | 21,270 | -- | 1,731,844 | 99.8% | Approved | — |
This meeting is also recorded here as June 16, 2026; both records come from the same filing, so the date should be checked against it.
Source: Madrigal Pharmaceuticals, Inc., Form 8-K, filed with the SEC on June 17, 2026 — read the filing on EDGAR.
Each item below shows how the 404 asset managers that disclosed a Madrigal Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Madrigal Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Re-election of Class I directors: Daniel Brennan
Madrigal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Daniel J. Brennan”): 19,469,200 for, 121,784 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders re-elected the three persons listed below as Class I directors, each to serve until the Company's 2029 annual meeting of stockholders or until his successor is duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,235,342 | 0 | 0 | 1,018 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 224,867 | 0 | 0 | 0 | For |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,302 | 0 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 63,133 | 0 | 0 | 0 | For |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| Brighthouse | 39,802 | 0 | 0 | 3,508 | Mixed |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
Fund voting reports, all 103 managers: 7,012,258 for, 21,026 withheld, 22 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 130,210 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 4 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 130,216 for.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Re-election of Class I directors: James Daly
Madrigal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: James M. Daly”): 18,921,185 for, 669,799 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders re-elected the three persons listed below as Class I directors, each to serve until the Company's 2029 annual meeting of stockholders or until his successor is duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,236,359 | 0 | 1 | 0 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 224,867 | Withhold |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,302 | 0 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 39,739 | 0 | 0 | 23,394 | Mixed |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| Brighthouse | 30,562 | 0 | 0 | 12,748 | Mixed |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
Fund voting reports, all 103 managers: 6,677,086 for, 356,197 withheld, 1 abstained, 22 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 130,210 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 4 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 130,216 for.
Combines 4 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: Re-election of Class I directors: Julian Baker
Madrigal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Julian C. Baker”): 17,363,250 for, 2,227,734 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders re-elected the three persons listed below as Class I directors, each to serve until the Company's 2029 annual meeting of stockholders or until his successor is duly elected and qualified.”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,740,728 | 0 | 5 | 495,627 | Mixed |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 224,867 | Withhold |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 1,282 | 0 | 0 | 161,020 | Withhold |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 39,739 | 0 | 0 | 23,394 | Mixed |
| Goldman Sachs | 57,022 | 0 | 0 | 982 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| Brighthouse | 30,562 | 0 | 0 | 12,748 | Mixed |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
Fund voting reports, all 103 managers: 5,946,086 for, 1,087,193 withheld, 5 abstained, 22 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 130,210 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 4 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 130,216 for.
99.9% of fund votes cast · no official result
The 103 asset managers below reported 7,003,016 for, 3,508 against, 22 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,236,360 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 224,867 | 0 | 0 | 0 | For |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,302 | 0 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 63,133 | 0 | 0 | 0 | For |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
| AllianceBernstein | 33,156 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
99.2% of fund votes cast · no official result
The 103 asset managers below reported 6,951,085 for, 55,439 against, 22 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,236,359 | 1 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 224,867 | 0 | 0 | 0 | For |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,297 | 5 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 63,133 | 0 | 0 | 0 | For |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 0 | 37,776 | 0 | 0 | Against |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
| AllianceBernstein | 33,156 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
Combines 8 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
Madrigal Pharmaceuticals, Inc.’s own tally for this item (“2. On a non-binding, advisory basis, the compensation of the Company's named executive officers”): 19,000,895 for, 561,058 against — passed, per its Form 8-K filed June 17, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,236,359 | 1 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 661,061 | 4,388 | 0 | 0 | For |
| BlackRock | 372,953 | 44,976 | 0 | 0 | Mixed |
| T. Rowe Price | 224,867 | 0 | 0 | 0 | For |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,239 | 63 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 63,133 | 0 | 0 | 0 | For |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| Brighthouse | 39,802 | 0 | 3,508 | 0 | Mixed |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
Fund voting reports, all 104 managers: 6,971,207 for, 58,570 against, 3,508 abstained, 22 not voted, 40 mixed. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 3,280,810 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 2,141,701 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,993,687 | 0 | 0 | 0 | For |
| Wellington | 663,183 | 0 | 0 | 0 | For |
| BlackRock | 576,592 | 66,347 | 0 | 0 | Mixed |
| PAULSON & CO. INC. | 593,825 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 547,284 | 0 | 0 | 0 | For |
| Fidelity | 466,664 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 458,203 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 400,077 | 0 | 0 | 0 | For |
| State Street | 341,917 | 188 | 0 | 0 | For |
| T. Rowe Price | 341,332 | 500 | 0 | 0 | For |
| Invesco | 302,566 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 288,709 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 234,067 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 219,809 | 0 | 0 | 0 | For |
| Charles Schwab | 218,490 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 173,138 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 170,999 | 0 | 0 | 0 | For |
| Vanguard | 155,161 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 152,782 | 0 | 0 | 0 | For |
| Northern Trust | 136,724 | 1,237 | 0 | 0 | For |
| American Century | 132,696 | 0 | 0 | 0 | For |
| Artisan | 132,579 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 130,210 | 0 | 0 | 0 | For |
Institutional-manager reports, all 327 managers: 16,158,500 for, 279,465 against, 3,366 abstained, 363 not voted. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026
Madrigal Pharmaceuticals, Inc.’s own tally for this item (“3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 21,256,315 for, 37,505 against — passed, per its Form 8-K filed June 17, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,236,360 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,109,777 | 0 | 0 | 0 | For |
| Fidelity | 665,449 | 0 | 0 | 0 | For |
| BlackRock | 417,929 | 0 | 0 | 0 | For |
| T. Rowe Price | 224,867 | 0 | 0 | 0 | For |
| Charles Schwab | 217,759 | 0 | 0 | 0 | For |
| Lord Abbett | 206,638 | 0 | 0 | 0 | For |
| Invesco | 192,756 | 0 | 0 | 0 | For |
| State Street | 162,297 | 5 | 0 | 0 | For |
| American Century | 115,417 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 99,605 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 97,264 | 0 | 0 | 0 | For |
| Jackson National | 84,511 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 65,128 | 0 | 0 | 0 | For |
| Equitable | 63,133 | 0 | 0 | 0 | For |
| Goldman Sachs | 58,004 | 0 | 0 | 0 | For |
| TIAA | 57,788 | 0 | 0 | 0 | For |
| Brighthouse | 39,802 | 0 | 3,508 | 0 | Mixed |
| HARBOR FUNDS | 43,301 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,063 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 39,609 | 0 | 0 | 0 | For |
| Voya | 38,676 | 0 | 0 | 0 | For |
| BNY Mellon | 38,557 | 0 | 0 | 0 | For |
| Putnam | 37,776 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 36,744 | 0 | 0 | 0 | For |
Fund voting reports, all 104 managers: 7,030,271 for, 5 against, 3,508 abstained, 22 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 130,210 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 500 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 4 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 130,716 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 23,041,918 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.71% |
| 2 | JANUS INVESTMENT FUND | 4.82% |
| 3 | Fidelity | 2.89% |
| 4 | BlackRock | 1.81% |
| 5 | T. Rowe Price | 0.98% |
| 6 | Charles Schwab | 0.95% |
| 7 | Lord Abbett | 0.90% |
| 8 | Invesco | 0.84% |
| 9 | State Street | 0.70% |
| 10 | American Century | 0.50% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 14.24% |
| 2 | BAKER BROS. ADVISORS LP | 9.29% |
| 3 | RTW INVESTMENTS, LP | 8.65% |
| 4 | Wellington | 2.88% |
| 5 | BlackRock | 2.79% |
| 6 | PAULSON & CO. INC. | 2.58% |
| 7 | Polar Capital Holdings Plc | 2.38% |
| 8 | Fidelity | 2.03% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.99% |
| 10 | Avoro Capital Advisors LLC | 1.74% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Avoro Capital Advisors LLC | 10.07% | DEF14A |
| Baker Bros. Advisors LP and affiliates | 10.07% | DEF14A |
| Julian Baker | 10.07% | DEF14A |
| JANUS HENDERSON GROUP PLC | 8.76% | 13G |
| RTW Investments, LP and affiliates | 8.65% | DEF14A |
| Vanguard Group | 7.85% | 13F |
| Paul Friedman, M.D. | 7.72% | DEF14A |
| Rebecca Taub, M.D. | 7.72% | DEF14A |
| Paulson & Co. Inc. and affiliates | 7.41% | DEF14A |
| BlackRock | 6.77% | 13F |
Percentages above are of 23,041,918 shares outstanding, as reported by Madrigal Pharmaceuticals, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Madrigal Pharmaceuticals, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Madrigal Pharmaceuticals, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 404 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,235 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION — Madrigal Pharmaceuticals, Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Madrigal Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2026.
Madrigal Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.